Business Description
Aarti Drugs Ltd
ISIN : INE767A01016
Share Class Description:
BOM:524348: Shs DematerialisedCompare
Compare
Traded in other countries / regions
524348.India IPO Date
1993-09-13Description
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.46 | |||||
| Debt-to-EBITDA | 2.01 | |||||
| Interest Coverage | 7.2 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.55 | |||||
| Beneish M-Score | -2.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.7 | |||||
| 3-Year EBITDA Growth Rate | -9.7 | |||||
| 3-Year EPS without NRI Growth Rate | -14.6 | |||||
| 3-Year FCF Growth Rate | 26.3 | |||||
| 3-Year Book Growth Rate | 12.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 12.4 | |||||
| 9-Day RSI | 19.75 | |||||
| 14-Day RSI | 23.99 | |||||
| 6-1 Month Momentum % | -11.8 | |||||
| 12-1 Month Momentum % | -7.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.61 | |||||
| Quick Ratio | 1.01 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 94.08 | |||||
| Days Sales Outstanding | 107.79 | |||||
| Days Payable | 80.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.24 | |||||
| Dividend Payout Ratio | 0.06 | |||||
| 3-Year Dividend Growth Rate | -26.3 | |||||
| Forward Dividend Yield % | 0.24 | |||||
| 5-Year Yield-on-Cost % | 0.61 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 0.8 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 19.38 | |||||
| Operating Margin % | 10.48 | |||||
| Net Margin % | 6.45 | |||||
| FCF Margin % | 5.62 | |||||
| ROE % | 12.12 | |||||
| ROA % | 6.33 | |||||
| ROIC % | 9.37 | |||||
| ROC (Joel Greenblatt) % | 12.95 | |||||
| ROCE % | 14.98 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.57 | |||||
| PE Ratio without NRI | 25.28 | |||||
| Shiller PE Ratio | 23.01 | |||||
| Price-to-Owner-Earnings | 17.3 | |||||
| PEG Ratio | 3.66 | |||||
| PS Ratio | 1.65 | |||||
| PB Ratio | 3.03 | |||||
| Price-to-Tangible-Book | 3.03 | |||||
| Price-to-Free-Cash-Flow | 29.4 | |||||
| Price-to-Operating-Cash-Flow | 10.86 | |||||
| EV-to-EBIT | 18.46 | |||||
| EV-to-EBITDA | 15.1 | |||||
| EV-to-Revenue | 1.88 | |||||
| EV-to-FCF | 33.41 | |||||
| Price-to-DCF (Earnings Based) | 1.38 | |||||
| Price-to-DCF (FCF Based) | 1.13 | |||||
| Price-to-Median-PS-Value | 1.23 | |||||
| Price-to-Graham-Number | 1.84 | |||||
| Price-to-Net-Current-Asset-Value | 37.28 | |||||
| Earnings Yield (Greenblatt) % | 5.42 | |||||
| FCF Yield % | 3.43 | |||||
| Forward Rate of Return (Yacktman) % | 8.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aarti Drugs Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 23,598.908 | ||
| EPS (TTM) (₹) | 16.58 | ||
| Beta | 0.87 | ||
| Volatility % | 32.78 | ||
| 14-Day RSI | 23.99 | ||
| 14-Day ATR (₹) | 11.276918 | ||
| 20-Day SMA (₹) | 449.7475 | ||
| 12-1 Month Momentum % | -7.27 | ||
| 52-Week Range (₹) | 420.05 - 634.9 | ||
| Shares Outstanding (Mil) | 91.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aarti Drugs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aarti Drugs Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aarti Drugs Ltd Frequently Asked Questions
What is Aarti Drugs Ltd(BOM:524348)'s stock price today?
The current price of BOM:524348 is ₹423.95. The 52 week high of BOM:524348 is ₹634.90 and 52 week low is ₹420.05.
When is next earnings date of Aarti Drugs Ltd(BOM:524348)?
The next earnings date of Aarti Drugs Ltd(BOM:524348) is 2025-01-24 Est..
Does Aarti Drugs Ltd(BOM:524348) pay dividends? If so, how much?
The Dividend Yield %  of Aarti Drugs Ltd(BOM:524348) is 0.24% (As of Today), Highest Dividend Payout Ratio of Aarti Drugs Ltd(BOM:524348) was 0.24. The lowest was 0.03. And the median was 0.05. The  Forward Dividend Yield % of Aarti Drugs Ltd(BOM:524348) is 0.24%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers